Q4 2016 13F Holders as of 12/31/2016
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
71.9M
-
Number of holders
-
280
-
Total 13F shares, excl. options
-
66.2M
-
Shares change
-
+897K
-
Total reported value, excl. options
-
$5.62B
-
Value change
-
+$86M
-
Put/Call ratio
-
339.38
-
Number of buys
-
130
-
Number of sells
-
-135
-
Price
-
$84.83
Significant Holders of WEST PHARMACEUTICAL SERVICES INC - Common Stock (WST) as of Q4 2016
321 filings reported holding WST - WEST PHARMACEUTICAL SERVICES INC - Common Stock as of Q4 2016.
WEST PHARMACEUTICAL SERVICES INC - Common Stock (WST) has 280 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 66.2M shares
of 71.9M outstanding shares and own 92.08% of the company stock.
Largest 10 shareholders include PRICE T ROWE ASSOCIATES INC /MD/ (9.81M shares), VANGUARD GROUP INC (6.05M shares), Neuberger Berman Group LLC (3.99M shares), FRANKLIN RESOURCES INC (3.95M shares), BlackRock Fund Advisors (2.82M shares), Select Equity Group, L.P. (2.73M shares), STATE STREET CORP (2.55M shares), BlackRock Institutional Trust Company, N.A. (2.19M shares), BAMCO INC /NY/ (2.14M shares), and JPMORGAN CHASE & CO (1.84M shares).
This table shows the top 280 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.